National Aeronautics and Space Administration November 9, 2016 – Federal Register Recent Federal Regulation Documents

The National Aeronautics and Space Administration (NASA) hereby gives notice of its intent to grant an exclusive license, in the field of use of human and/or animal healthcare, in the Australia, Brazil, Canada, China, Chile, Colombia, Hong Kong, European Union (EPO), India, Indonesia, Israel, Japan, Malaysia, Mexico, New Zealand, Philippines, Russia, Saudi Arabia, Singapore, South Africa, South Korea, United States and Vietnam, to practice the inventions described and claimed in Patent Cooperative Treaty (PCT) Application Number PCT/ US15/20964 and national/regional phase patent applications resulting therefrom, titled ``Infrasonic Stethoscope for Monitoring Physiological Processes,'' NASA Case Number LAR-18509-1-PCT, to Infrasonix Inc., having its principal place of business in Lawrenceville, GA. Certain patent rights in these inventions have been assigned to the United States of America as represented by the Administrator of the National Aeronautics and Space Administration. The prospective exclusive license will comply with the terms and conditions of 35 U.S.C. 209 and 37 CFR 404.7.